Tenascin-C signaling through induction of 14-3-3 tau

We searched by a cDNA subtraction screen for differentially expressed transcripts in MCF-7 mammary carcinoma cells grown on tenascin-C versus fibronectin. On tenascin-C, cells had irregular shapes with many processes, whereas on fibronectin they were flat with a cobble stone–like appearance. We found elevated levels of 14-3-3 tau transcripts and protein in cells grown on tenascin-C. To investigate the consequences of an increased level of this phospho-serine/threonine–binding adaptor protein, we transfected MCF-7 cells with a construct encoding full-length 14-3-3 tau protein and selected clones with the highest expression levels. The morphology of these cells on tenascin-C was flat, resembling that of cells on fibronectin. This was reflected by a similar pattern of F-actin staining on either substratum. Furthermore, the growth rate on tenascin-C was increased compared with the parental cells. After transient transfection of HT1080 fibrosarcoma and T98G glioblastoma cells with 14-3-3 tau, only the 14-3-3 tau–expressing cells were able to adhere and survive on tenascin-C, whereas all cells adhered well on fibronectin. Therefore, we postulate that tenascin-C promotes the growth of tumor cells by causing an increase in the expression of 14-3-3 tau, which in turn has a positive effect on tumor cell adhesion and growth.

[1]  H. Betz,et al.  Identification of cofilin and LIM-domain-containing protein kinase 1 as novel interaction partners of 14-3-3 zeta. , 2003, The Biochemical journal.

[2]  G. Bokoch,et al.  14-3-3 Regulates Actin Dynamics by Stabilizing Phosphorylated Cofilin , 2002, Current Biology.

[3]  Takashi Tsuruo,et al.  Akt-dependent Phosphorylation of p27Kip1Promotes Binding to 14-3-3 and Cytoplasmic Localization* , 2002, The Journal of Biological Chemistry.

[4]  S. Bell,et al.  Changes in tenascin-C isoform expression in invasive and preinvasive breast disease. , 2002, Cancer research.

[5]  Margareta M. Mueller,et al.  Clinical impact and functional aspects of tenascin‐C expression during glioma progression , 2002, International journal of cancer.

[6]  J. Avruch,et al.  14-3-3 Proteins: Active Cofactors in Cellular Regulation by Serine/Threonine Phosphorylation* , 2002, The Journal of Biological Chemistry.

[7]  J. Moyano,et al.  Interference of tenascin-C with syndecan-4 binding to fibronectin blocks cell adhesion and stimulates tumor cell proliferation. , 2001, Cancer research.

[8]  S. Masters,et al.  14-3-3 Proteins Mediate an Essential Anti-apoptotic Signal* , 2001, The Journal of Biological Chemistry.

[9]  P. Heikkilä,et al.  Increased Expression of Tenascin in Pheochromocytomas Correlates With Malignancy , 2001, The American journal of surgical pathology.

[10]  M. V. van Hemert,et al.  14‐3‐3 proteins: key regulators of cell division, signalling and apoptosis , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.

[11]  Y. Nakajima,et al.  Annexin II overexpression correlates with stromal tenascin‐C overexpression , 2001, Cancer.

[12]  J. Bos,et al.  Rap1 signalling: adhering to new models , 2001, Nature Reviews Molecular Cell Biology.

[13]  J. Guan,et al.  Identification of a novel interaction between integrin β1 and 14-3-3β , 2001, Oncogene.

[14]  D. C. Han,et al.  Identification of a novel interaction between integrin beta1 and 14-3-3beta. , 2001, Oncogene.

[15]  H. Koelbl,et al.  Tenascin-A marker for the malignant potential of preinvasive breast cancers. , 2000, Gynecologic oncology.

[16]  P. Jones,et al.  Tenascin-C in development and disease: gene regulation and cell function. , 2000, Matrix biology : journal of the International Society for Matrix Biology.

[17]  R. Chiquet‐Ehrismann,et al.  Adhesion modulation by antiadhesive molecules of the extracellular matrix. , 2000, Experimental cell research.

[18]  Y. Takihara,et al.  Role of the β isoform of 14-3-3 proteins in cellular proliferation and oncogenic transformation , 2000 .

[19]  G. Berruti.  A novel rap1/B-Raf/14-3-3 theta protein complex is formed in vivo during the morphogenetic differentiation of postmeiotic male germ cells. , 2000, Experimental cell research.

[20]  W. V. van Blitterswijk,et al.  Protein kinase C activation by acidic proteins including 14-3-3. , 2000, The Biochemical journal.

[21]  Anthony J. Muslin,et al.  14‐3‐3 proteins block apoptosis and differentially regulate MAPK cascades , 2000, The EMBO journal.

[22]  S. Masters,et al.  14-3-3 proteins: structure, function, and regulation. , 2000, Annual review of pharmacology and toxicology.

[23]  A. Kumagai,et al.  Binding of 14-3-3 proteins and nuclear export control the intracellular localization of the mitotic inducer Cdc25. , 1999, Genes & development.

[24]  T. Schulthess,et al.  Concerted action of tenascin-C domains in cell adhesion, anti-adhesion and promotion of neurite outgrowth. , 1997, Journal of cell science.

[25]  G. Vollmer.  Biologic and oncologic implications of tenascin-C/hexabrachion proteins. , 1997, Critical reviews in oncology/hematology.

[26]  Elizabeth Yang,et al.  Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL , 1996, Cell.

[27]  K. Crossin,et al.  Tenascin: A multifunctional extracellular matrix protein with a restricted distribution in development and disease , 1996, Journal of cellular biochemistry.

[28]  T. Mustelin,et al.  Inhibition of phosphatidylinositol 3-kinase activity by association with 14-3-3 proteins in T cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[29]  W. Kolch,et al.  Regulation of Raf‐1 kinase activity by the 14‐3‐3 family of proteins. , 1995, The EMBO journal.

[30]  W. Fantl,et al.  Activation of Raf-1 by 14-3-3 proteins , 1994, Nature.

[31]  K. Xia,et al.  Interaction of the protein kinase Raf-1 with 14-3-3 proteins. , 1994, Science.

[32]  R. Chiquet‐Ehrismann.  Tenascin and other adhesion-modulating proteins in cancer. , 1993, Seminars in cancer biology.

[33]  R. Chiquet‐Ehrismann,et al.  Participation of tenascin and transforming growth factor-beta in reciprocal epithelial-mesenchymal interactions of MCF7 cells and fibroblasts. , 1989, Cancer research.

[34]  R. Chiquet‐Ehrismann,et al.  Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis , 1986, Cell.